Extended Data Table 4 Circulating tumor cells enumeration and composition in the untreated control patients

From: Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trial

  1. Table describing the volume of blood analyzed, the total number of single CTCs, the total number of CTC clusters, the number of homotypic CTC clusters and the number of heterotypic CTC-WBC clusters per 7.5 ml of peripheral blood, and the average cluster size.